Rhumbline Advisers Invitae Corp Transaction History

Rhumbline Advisers

$103 Billion
Q1 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$0.42 - $0.72 $333 - $571	794 Added 0.23%	352,399 $222,000
Q3 2023 Nov 09, 2023	BUY	$0.6 - $1.53 $1,777 - $4,533	2,963 Added 0.85%	351,605 $210,000
Q2 2023 Aug 08, 2023	SELL	$1.05 - $1.63 $44,305 - $68,779	-42,196 Reduced 10.8%	348,642 $393,000
Q1 2023 May 11, 2023	BUY	$1.2 - $2.73 $18,957 - $43,128	15,798 Added 4.21%	390,838 $528,000
Q4 2022 Feb 14, 2023	BUY	$1.71 - $3.61 $11,056 - $23,342	6,466 Added 1.75%	375,040 $698,000

Q3 2022 Nov 10, 2022	BUY	$1.9 - $8.63 $57,611 - $261,678	30,322 Added 8.96%	368,574 $907,000
Q2 2022 Aug 11, 2022	BUY	$2.13 - $9.01 $172,998 - $731,792	81,220 Added 31.6%	338,252 $825,000
Q1 2022 May 12, 2022	SELL	$6.28 - $15.59 $85,747 - $212,865	-13,654 Reduced 5.04%	257,032 $2.05 Million
Q4 2021 Feb 10, 2022	SELL	$14.7 - $28.67 $3,131 - $6,106	-213 Reduced 0.08%	270,686 $4.13 Million
Q3 2021 Nov 12, 2021	SELL	$24.31 - $33.6 $63,959 - $88,401	-2,631 Reduced 0.96%	270,899 $7.7 Million
Q2 2021 Aug 05, 2021	BUY	$26.09 - $40.4 $3.41 Million - $5.28 Million	130,733 Added 91.55%	273,530 $9.23 Million
Q1 2021 May 06, 2021	SELL	$33.06 - $56.93 $242,462 - $417,524	-7,334 Reduced 4.89%	142,797 $5.46 Million
Q4 2020 Feb 10, 2021	BUY	$39.09 - $57.4 $289,226 - $424,702	7,399 Added 5.18%	150,131 $6.28 Million
Q3 2020 Nov 12, 2020	SELL	$28.43 - $44.67 $998,632 - $1.57 Million	-35,126 Reduced 19.75%	142,732 $6.19 Million
Q2 2020 Aug 13, 2020	BUY	$11.71 - $30.29 $627,878 - $1.62 Million	53,619 Added 43.16%	177,858 $5.39 Million
Q1 2020 May 06, 2020	BUY	$7.64 - $27.5 $26,388 - $94,985	3,454 Added 2.86%	124,239 $1.7 Million
Q4 2019 Feb 05, 2020	BUY	$15.02 - $20.57 $78,134 - $107,005	5,202 Added 4.5%	120,785 $1.95 Million
Q3 2019 Oct 23, 2019	BUY	$18.85 - $27.5 $31,781 - $46,365	1,686 Added 1.48%	115,583 $2.23 Million
Q2 2019 Aug 14, 2019	BUY	$17.37 - $26.27 $363,884 - $550,330	20,949 Added 22.54%	113,897 $2.68 Million
Q1 2019 May 01, 2019	BUY	$10.65 - $25.75 $70,460 - $170,362	6,616 Added 7.66%	92,948 $2.18 Million
Q4 2018 Jan 31, 2019	BUY	$9.26 - $16.38 $269,567 - $476,838	29,111 Added 50.87%	86,332 $955,000
Q3 2018 Nov 07, 2018	SELL	$7.54 - $18.31 $22,009 - $53,446	-2,919 Reduced 4.85%	57,221 $957,000
Q2 2018 Aug 06, 2018	BUY	$4.87 - $8.42 $108,123 - $186,940	22,202 Added 58.52%	60,140 $442,000
Q1 2018 May 02, 2018	BUY	$4.69 - $10.05 $8,981 - $19,245	1,915 Added 5.32%	37,938 $178,000
Q4 2017 Feb 09, 2018	SELL	$7.86 - $9.99 $57,991 - $73,706	-7,378 Reduced 17.0%	36,023 $327,000
Q3 2017 Nov 06, 2017	BUY	$8.89 - $10.4 $385,834 - $451,370	43,401	43,401 $407,000

Others Institutions Holding NVTA

# of Institutions

Shares Held

7.66M

Call Options Held

Put Options Held

View Full List

About Invitae Corp

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

More about NVTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account